UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors

British journal of cancer, 2014-12, Vol.111 (12), p.2268-2274

2014

Volltextzugriff (PDF)

Paclitaxel (Taxol) : An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer

Cancer biotherapy & radiopharmaceuticals, 1999-02, Vol.14 (1), p.31-36

1999

Volltextzugriff (PDF)

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3078-3081

1998

Volltextzugriff (PDF)

Severe esophageal toxicity after thoracic radiation therapy for lung cancer associated with the human immunodeficiency virus: A case report and review of the literature

American journal of clinical oncology, 1998-10, Vol.21 (5), p.479-481

1998

Volltextzugriff (PDF)

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1728-1733

2001

Volltextzugriff (PDF)

Characterization of Covalent DNA Binding of Morpholino and Cyanomorpholino Derivatives of Doxorubicin

JNCI : Journal of the National Cancer Institute, 1992-10, Vol.84 (20), p.1587-1592

1992

Volltextzugriff (PDF)

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

Integrative cancer therapies, 2019-01, Vol.18, p.1534735419836501-1534735419836501

2019

Volltextzugriff (PDF)

Molecular–clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach

Lung cancer, 2001-12, Vol.34, p.75-80

2001

Volltextzugriff (PDF)

Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker

British journal of cancer, 1994-07, Vol.70 (1), p.79-84

1994

Volltextzugriff (PDF)

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide : a Southwest Oncology Group clinical and pharmacokinetic study

Cancer chemotherapy and pharmacology, 1999, Vol.44 (6), p.461-468

1999

Volltextzugriff (PDF)

Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes

Cancer research (Chicago, Ill.), 1992-08, Vol.52 (16), p.4379-4384

1992

Volltextzugriff (PDF)

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group Study

Cancer chemotherapy and pharmacology, 1997, Vol.41 (1), p.75-78

1997

Volltextzugriff (PDF)

Concurrent carboplatin, etoposide and thoracic radiation for poor-risk Stage III non-small-cell lung carcinoma: A pilot study

International journal of radiation oncology, biology, physics, 1997-04, Vol.38 (1), p.157-161

1997

Volltextzugriff (PDF)

Identification of novel targeting peptides for human ovarian cancer cells using “one-bead one-compound” combinatorial libraries

Molecular cancer therapeutics, 2005-05, Vol.4 (5), p.806-813

2005

Volltextzugriff (PDF)

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : Carboplatin and gemcitabine followed by paclitaxel

Cancer, 2001-07, Vol.92 (1), p.146-152

2001

Volltextzugriff (PDF)

Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues

Cancer chemotherapy and pharmacology, 1996, Vol.38 (3), p.210-216

1996

Volltextzugriff (PDF)

Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism

International journal of radiation oncology, biology, physics, 1992, Vol.22 (4), p.821-824

1992

Volltextzugriff (PDF)

Loss of nm23 and Alu DNA in human lung cancer propagated in nude mice

Cancer letters, 1995-11, Vol.97 (2), p.163-168

1995

Volltextzugriff (PDF)

Association of DNA Cross-Linking With Potentiation of the Morpholino Derivative of Doxorubicin by Human Liver Microsomes

JNCI : Journal of the National Cancer Institute, 1989-07, Vol.81 (13), p.1034-1038

1989

Volltextzugriff (PDF)

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin

Cancer research (Chicago, Ill.), 1991-10, Vol.51 (19), p.5181-5187

1991

Volltextzugriff (PDF)

Treatment of extensive small cell lung cancer

Hematology/oncology clinics of North America, 2004-04, Vol.18 (2), p.373-385

2004

Volltextzugriff (PDF)

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

The cancer journal (Sudbury, Mass.), 2004-09, Vol.10 (5), p.294-300

2004

Volltextzugriff (PDF)

Neoadjuvant therapy for non-small cell lung cancer

Anti-cancer drugs, 2001-02, Vol.12 Suppl 1, p.S5-S9

2001

Volltextzugriff (PDF)

Gemcitabine in combination with new platinum compounds: an update

Oncology (Williston Park, N.Y.), 2001-03, Vol.15 (3 Suppl 6), p.13

2001

Volltextzugriff (PDF)

Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin

Cancer research (Chicago, Ill.), 1990-07, Vol.50 (13), p.4056-4060

1990

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Aktive Filter

KollektionAPS: American Physical Society E-Journals (Physics)

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(169)

Publikationsform

Artikel
(186)

Sprache

Englisch
(186)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors

Paclitaxel (Taxol) : An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

Severe esophageal toxicity after thoracic radiation therapy for lung cancer associated with the human immunodeficiency virus: A case report and review of the literature

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Characterization of Covalent DNA Binding of Morpholino and Cyanomorpholino Derivatives of Doxorubicin

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy

Molecular–clinical correlative studies in non-small cell lung cancer: application of a three-tiered approach

Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide : a Southwest Oncology Group clinical and pharmacokinetic study

Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group Study

Concurrent carboplatin, etoposide and thoracic radiation for poor-risk Stage III non-small-cell lung carcinoma: A pilot study

Identification of novel targeting peptides for human ovarian cancer cells using “one-bead one-compound” combinatorial libraries

Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : Carboplatin and gemcitabine followed by paclitaxel

Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues

Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism

Loss of nm23 and Alu DNA in human lung cancer propagated in nude mice

Association of DNA Cross-Linking With Potentiation of the Morpholino Derivative of Doxorubicin by Human Liver Microsomes

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin

Treatment of extensive small cell lung cancer

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

Neoadjuvant therapy for non-small cell lung cancer

Gemcitabine in combination with new platinum compounds: an update

Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin

Aktive Filter

Suchergebnisse filtern